Update on “Risk Play for 8/24” Jazz Pharmaceuticals

Jazz Pharmaceuticals (JAZZ) is up over 15% since I suggested it as a risk play one week ago on August 23rd. I pegged it for oversold on headlines as it has since gained back half of its share price before the selloff. Perhaps if you bought the stock when I suggested it, you made away with some attractive profits.

Happy trading and hopefully I will get to recommending another risk play soon.


About Aaron Basile
Market Technician, Equity/Commodity Trader, Austrian Economist, Contrarian Investor

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: